Opinion: Garland s Appointment a Beacon in Cannabis Insurance Space insurancejournal.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insurancejournal.com Daily Mail and Mail on Sunday newspapers.
Biden-Harris Can Do It!
Campaign Urges Biden-Harris Administration to Take Action Now!
Now that medical cannabis is getting some recognition federally, we cannot sit back and relax, we must push harder than ever until there is safe and affordable access for everyone in the country.” Debbie Churgai, Executive Director of Americans for Safe Access
WASHINGTON, DC, UNITED STATES, March 2, 2021 /EINPresswire.com/ Washington, DC Today, Americans for Safe Access (ASA) launched its Biden-Harris Can Do It: No Patient Left Behind campaign to seize the first 100 days of the new Biden- Harris administration as an opportunity to influence medical cannabis policies and mobilize a movement to pass comprehensive federal legislation in the 117th Congress.
AG pick Merrick Garland: not a useful use of DOJ resources to go after state-legal cannabis • A compromise in South Dakota? • & more cannabiswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cannabiswire.com Daily Mail and Mail on Sunday newspapers.
Will the Federal Government Finally Embrace the Psychedelic Revolution?
Will the Federal Government Finally Embrace the Psychedelic Revolution?
From approving religious exemptions to budgeting for medical research, advocates are hopeful that Biden and a Democratic Congress could mean progress for psilocybin and other therapeutic psychedelics
Shelby Hartman, provided by
FacebookTwitterEmail
This column is a collaboration with DoubleBlind, a print magazine and media company at the forefront of the psychedelic movement.
Psychedelic reform isn’t exactly President Joe Biden’s top priority. But as his administration and the new congress gets underway, advocates are hopeful that the next four years will continue to bring policy changes that chip away at the federal prohibition of psilocybin, MDMA, and other psychedelics.